Skip to main content
. Author manuscript; available in PMC: 2020 Aug 28.
Published in final edited form as: J Alzheimers Dis. 2020;76(4):1215–1242. doi: 10.3233/JAD-200282

Table 1.

Epidemiology literature summary for lead exposure and Alzheimer’s disease or cognitive decline

Reference Study Design Population Exposure Outcome Main Findings
Alzheimer’s Disease
Graves, 1991 [224] Meta-analysis Four case-control studies of AD in 4 US cities (Bedford, Durham, Denver, Minneapolis); 221 cases and 287 controls Exposure to Pb at work AD (unspecified) RR = 0.71 (95% CI: 0.36–1.41)
Emard, 1994 [63] Retrospective ecological 129 definite or probable AD cases born in the Saguenay-Lac-Saint-Jean territory of Quebec Difference between birthplace residential and municipal average levels of Pb in soil AD clinical diagnosis Number of cases with higher average Pb concentration near residence at birth in comparison to municipal average (n = 49) differs from number of cases with lower average Pb concentrations near residence at birth in comparison to municipal average (n = 15) P <0.05
Gun, 1997 [56] Case-control 170 newly referred cases of probable or possible AD from 2 hospitals in Sydney, Australia; 170 age- and sex-matched individuals recruited from general practice Exposure status based on interview and occupational exposure information (never, possible, probable) AD clinical diagnosis OR=1.12 (95% CI: 0.63–2.00) of AD for possible/probable versus never exposure
Cognitive function
Stokes, 1998 [225] Retrospective cohort 257 young adults ages 19–29 who lived 5 towns surrounding lead smelter in Silver Valley, ID (exposed) versus 276 licensed drivers ages 19–29 living in Spokane, WA (referent) Living in one of 5 towns surrounding lead smelter while 9 months to 9 years of age from 1974–1975 CNS outcomes including cognitive, mood, and Swedish Q16 The exposed (versus the referent) was associated with 0.169 seconds longer on concept shifting task; 0.117 more errors on symbol digit substitution; 0.155 more errors on learning/attention task (serial digit learning); 0.115 more errors on non-verbal intelligence task, and 0.167
Payton, 1998 [57] Cross-sectional A subset of 141 men from the NAS (mean age 66.8, SD: 6.8) Blood Pb (μg/dl), patella Pb and tibia Pb (ĝ Pb/g bone mineral) Neuropsych battery including portions of NES2, WAIS-R and CERAD fewer correct on vocabulary test Blood Pb (1 μg/dl increase) was associated with 0.84 (SE: 0.2) fewer points on the vocabulary test, 0.18 (SE: 0.09) fewer words recalled on word memory test, and 0.1 (SE: 0.04/) fewer points on the spatial copying test.
Tibia Pb (1 μg Pb/g bone increase) is associated with 0.031 (SE: 0.012) fewer points on the spatial copying test.
Wright, 2003 [58] Cross-sectional A subset of 736 men from NAS (mean age 68.2, SD: 6.9) Blood Pb (μg/dl), patella Pb and tibia Pb (μg Pb/g bone mineral) MMSE score OR = 2.1 (95% CI 1.1–4.1) of MMSE<24 for highest versus lowest quartile of patella Pb
OR = 3.4 (95% CI 1.6–6.2) of MMSE<24 for highest versus lowest quartile of blood Pb
Weisskopf, 2004 [61] Prospective A subset of 466 men from NAS (mean age 67.6, SD 6.6) Blood Pb (μg/dl), patella Pb and tibia Pb (μg Pb/g bone mineral) MMSE score on two separate occasions, average 3.5 years (SD 1.1) apart 1 IQR (20 μg/g of bone mineral) higher patella Pb was associated with −0.24 (95% CI: −0.44, −0.05) points on MMSE.
1 IQR (14 μg/g bone mineral) higher tibia Pb was associated with −0.17 (95% CI: −0.38, 0.04) points on MMSE.
Shih, 2006 [59] Cross-sectional Subset of 985 participants of the Baltimore Memory Study (mean age 59.39, SD: 5.96), a longitudinal cohort study of adults randomly selected from 65 neighborhoods in Baltimore, MD. Blood Pb (μg/dL), tibia Pb (μg/g bone) Scores for testing in 7 cognitive domains (language, processing speed, hand-eye coordination, executive functioning, verbal memory and learning, visual memory, and visuoconstruction Tibia Pb associated with −0.0046 (SE: 0.002) change in language domain average z-score, −0.0053 (SE: 0.018) change in executive functioning domain average z-score,−0.0054 (SE: 0.0023) change in visual memory and learning domain average z-score, −0.0046 (SE: 0.0023) change in visual memory domain average z-score, −0.0091 (SE: 0.0025) change in visuoconstruction domain average z-score.
Farooqui, 2017 [62] Longitudinal A subset of men from the NAS, 741 with MMSE scores (mean age 67.77, SD: 6.82), 715 with global cognition measures (mean age 68.43, SD: 7.11) Patella and tibia Pb (μg/g bone) MMSE; Global cognition score (average Z-score from 6 tests from NES2, CERAD, and WAIS-R) 21 μg/g higher patella Pb (1 IQR) associated with −0.13 lower baseline MMSE (95% CI: −0.25, −0.004) and faster longitudinal MMSE decline (−0.016 units/year, 95% CI: −0.032, −0.0004), and increased risk of MMSE score below 25 (HR = 1.21, 95% CI: 0.99, 1.49).

AD, Alzheimer’s disease; RR, relative risk; OR, odds ratio; SD, standard deviation; NAS, VA Normative Aging Study; NES2, Neurobehavioral Evaluation System 2; WAIS-R, Weschler Adult Intelligence Scale; CERAD, Consortium to Establish a Registry for Alzheimer’s Disease; ALS, amyotrophic lateral sclerosis; SE, standard error; CI, confidence interval; K-XRF, K-Shell X-ray fluorescence; MMSE, Mini-Mental State Examination; PNS, peripheral nervous system; CNS, central nervous system; HR, hazard ratio